Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Akers Biosciences (NQ: AKER )

3.330 USD -0.080 (-2.35%)
Official Closing Price Updated: 7:40 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Akers Biosciences

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
80 Biggest Movers From Yesterday
Gainers NantKwest, Inc. (NASDAQ: NK) shares surged 37.27 percent to close at $3.72 on Thursday. Releasing the first human clinical ... 
Tags QBAK ENDP SBH
From Benzinga
65 Stocks Moving In Thursday's Mid-Day Session
Gainers I-AM Capital Acquisition Company (NASDAQ: IAM) shares rose 55.2 percent to $9.34. NantKwest, Inc. (NASDAQ: NK) shares ... 
Tags CRWS Health Care ROKU
From Benzinga
35 Stocks Moving In Thursday's Pre-Market Session
Gainers NantKwest, Inc. (NASDAQ: NK) shares rose 23.6 percent to $3.35 in pre-market trading after disclosing promising first in ... 
Tags CIFS AVGO CYBR
From Benzinga
Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that the Board of Directors has initiated a process... 
From GlobeNewswire News Releases
Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PTC Therapeutics, Inc.... 
From GlobeNewswire News Releases
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces a leadership change, an update to the Company’s... 
From GlobeNewswire News Releases
FOCUS-Norway's Aker bets on software engineers for its oil business
When the owners of Norwegian oil firm Aker BP decided to digitise its assets and operations, they searched high and low for the right software company. But they failed to find a suitable one. 
Tags companyNews
From Reuters: Company News
Stocks to Watch for September 13, 2018
Tags NSPR TLRY IQ
From AC Investor Blog
Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy — Emerging Consolidated Expectations, Anal
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Addus HomeCare Corporation... 
From GlobeNewswire News Releases
The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags Earnings OCX ELGX
From Benzinga
Akers Biosciences Announces Q2 and H1 2018 Earnings
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports its financial results for the three months and six... 
From GlobeNewswire News Releases
AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case – AKER
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akers Biosciences, Inc. (NASDAQ:AKER) from May 15, 2017 through June 5, 2018 (the “Class Period”) of the... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ: AKER) and certain of its officers. The class action, filed in... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ: AKER) and certain of its officers. The class action, filed in... 
From GlobeNewswire News Releases
The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER) 
From Business Wire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E, Akers Biosciences, and UNUM and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of PG&E Corporation, Akers Biosciences, Inc., and UNUM Group. Stockholders have... 
From GlobeNewswire News Releases
August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. 
From Business Wire News Releases
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akers Biosciences, Inc. Investors
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akers Biosciences, Inc. Investors 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
From ACCESSWIRE
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. 
From Business Wire News Releases
AKER ALERT NOTICE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First File Case – AKER
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the “Class Period”) of the... 
From GlobeNewswire News Releases
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline: August 13, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ: AKER) and... 
From GlobeNewswire News Releases
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ: AKER) and certain of its officers. The class action, filed in... 
From GlobeNewswire News Releases
AKERS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akers Biosciences, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) of the August 13, 2018 deadline to seek the role of... 
From PR Newswire
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER) 
From Business Wire News Releases
Lifshitz & Miller LLP Announces Investigation of Ankers Biosciences, Inc., Cotiviti Holdings, Inc., Energy XXI Gulf Coast, Inc., Enterprise Bank N.J., First Connecticut Bancorp, Inc., QUALCOMM Incorpo
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
From ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline: August 13, 2018
From ACCESSWIRE
NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit on behalf of Akers Biosciences, Inc. Investors; Important August Deadline – AKER
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15,... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.